Search for: "United States v. Cartwright" Results 1 - 20 of 45
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Feb 2016, 7:31 am by Jack Sharman
Michael Landon (“Little Joe Cartwright”) being served with a subpoena (1968) Another useful Townsend post addresses a common issue — the Government’s attempt to muzzle the recipients of subpoenas: In United States v. [read post]
20 Apr 2015, 6:30 am
Yücel is a citizen of Sweden . . ., and was extradited from the Republic of Moldova to the United States in May 2014.U.S. v. [read post]
21 Jul 2014, 4:14 pm by TEI Expert
For example, an apartment complex may be sued because a woman who was assaulted in her unit believes the premises were inadequately secured (Kennedy and Hupp 1998). [read post]
13 Mar 2014, 12:22 pm by Brenda Fulmer
Under current law, as confirmed by the United States Supreme Court in the Pliva v. [read post]
13 Sep 2013, 9:34 am by Schachtman
  Most lawyers in the United States would think it malpractice to engage in such a practice. [read post]
20 Aug 2013, 5:00 am by Kimberly A. Kralowec
Supreme Court Order (01/11/12): In light of the United States Supreme Court's order vacating our judgment in the above-entitled case and remanding the cause to this court "for further consideration in light of AT&T Mobility LLC. v. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
Interestingly, Plaintiffs assume that Ranbaxy maintains 180-day exclusivity eligibility for generic NEXIUM; however, as we previously noted there has been speculation that Ranbaxy’s ANDA for generic NEXIUM Delayed-release Capsules is one of the unidentified ANDAs in the Consent Decree the United States filed against Ranbaxy earlier this year and for which Ranbaxy agreed to forfeit 180-day exclusivity.  [read post]
9 Mar 2012, 6:30 am by Howard Ullman
The plaintiff developed and marketed a pharmaceutical product, and contracted with CoTherix to commercialize the product in the United States. [read post]